drugset

drugset / Trial / NCT06525636

A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

NCT06525636 ↗

Phase 1/2 Recruiting 24 enrolled Kyowa Kirin, Inc.

Non-randomizedSequentialOpen-labelTreatment

Summary

A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.

Timeline

Start: 2024-10-09
Primary completion: 2028-02-11
Completion: 2028-05-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	KK8123	Unknown	—	Subcutaneous

Indications